3 January 2025

The first three chapters of “ConoceRte” are now available, an innovative Aragonese podcast on youth mental health

Thanks to the coordination of the IIS Aragón, this project is part of the Research Group on Digital Communication and Information (GICID) of UNIZAR, in collaboration with ASAPME Aragón and sponsored by Johnson & Johnson, with the aim of making mental health treatment in young people and adolescents visible and normal. The first three chapters are now available.
1 January 2025

Key bridge revealed in genetic communication of craniofacial development

A study co-led by the Alicante Institute of Neurosciences has discovered the genes that control cell migration, which is the basis for the development of facial structure. The work opens the way to a better understanding of the genetic causes behind certain congenital diseases.
30 December, 2024

A new drug improves clinical outcomes for patients with advanced breast cancer

A Phase 3 clinical trial demonstrates that the combination of imlunestrant and abemaciclib improves progression-free survival in advanced ER+ HER2- breast cancer, regardless of genomic profile. The compound as monotherapy only shows benefits in patients with mutations in the ESR1 gene.
27 December, 2024

A group of researchers develop an AI model to predict the risk of metabolic disorders in children with obesity

The system integrates epigenetic clinical data, allowing early detection and personalized prevention of metabolic complications, especially during puberty, a key stage to avoid future cardiovascular diseases.
26 December, 2024

A researcher from IIS Aragón chosen to represent women scientists in “Pioneers”

Rebeca Sanz, principal investigator of the Cancer Heterogeneity and Immunonomics group, is the star of the new edition of the Teruel Provincial Council calendar along with 11 other women from Bajo Aragón who are leaders in their fields.